Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
4(57.1%)
N/A
2(28.6%)
Early Phase 1
1(14.3%)
7Total
Phase 3(4)
N/A(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07348640Phase 3Not Yet Recruiting

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

Role: collaborator

NCT02201537Not ApplicableCompleted

Kidney Disease and Ultrasound Imaging

Role: collaborator

NCT06010173Phase 3Completed

Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children

Role: collaborator

NCT02748941Not ApplicableRecruiting

Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control

Role: collaborator

NCT06406517Phase 3Not Yet Recruiting

Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

Role: collaborator

NCT01253213Early Phase 1Completed

BR55 in Prostate Cancer: an Exploratory Clinical Trial

Role: collaborator

NCT00911027Phase 3Terminated

SonoVue Guided Prostate Biopsy

Role: collaborator

All 7 trials loaded